Alexandre Poulain is a Full Professor in the Department of Biology at the University of Ottawa and Vice Dean for Research and Infrastructure in the Faculty of Science. His multidisciplinary research bridges biogeochemistry, microbial physiology, and environmental toxicology. Education: B.Sc. (Angers, France), M.Sc. (INRS, Canada), Ph.D. (Université de Montréal, Canada), Postdoc (MIT, USA) Research Interests: Mercury cycling in Arctic and temperate ecosystems, microbial metal transformations, biosensor development for contaminants, redox reaction dynamics, bioremediation using environmental microbes, and mercury-organic matter interactions. His lab (2017-2025) has produced 15 recent publications on mercury biogeochemistry in oil sands, rice paddies, and Arctic lakes, alongside arsenic speciation studies and pesticide impacts on pollinators. Current students explore archaeal mercury regulators, acidothermophilic biosensors, and microbial remediation. Scientific contributions include: NSERC Postdoctoral Fellowship (2007-2009) Co-PI on Microbright, a startup commercializing microbial water treatment Developed portable arsenic biosensor tested in Cambodia Co-edited mercury-climate synthesis in Nature Communications
Dr. Nicola Allison is a Reader at the University of St Andrews, School of Earth & Environmental Sciences, where she leads research on biomineralisation. Her work focuses on how marine organisms form calcium carbonate structures, the impact of environmental changes on these processes, and the role of these biominerals in reconstructing past climates. Her research integrates experimental studies using controlled aquaria systems to culture corals and other organisms, alongside geochemical analyses of fossil carbonates. Key areas include the effects of ocean acidification, rising temperatures, and organic matrices on biomineral formation. She collaborates internationally, including through the International Ocean Discovery Program (IODP). Publications highlight advancements in understanding coral skeletal chemistry, aragonite precipitation mechanisms, and the development of climate proxies. She holds grants from NERC, MASTS, and the Leverhulme Trust, supporting projects on coral calcification, biomolecule influences, and climate change impacts. Dr. Allison actively engages in public outreach through workshops and conferences, contributing to climate science communication and policy-relevant research on marine ecosystems.
Professor Jill Edmondson serves as a Professor of Ecosystem Sustainability and NERC Knowledge Exchange Fellow at the School of Biosciences, University of Sheffield, where she has been a Senior Lecturer since 2021. Her research focuses on enhancing ecosystem sustainability and resilience in urban and agricultural contexts through interdisciplinary approaches bridging soil science, plant ecology, and social dimensions. Her core research pillars include: Urban Horticulture , where she leads the national MYHarvest citizen science project quantifying home-grown food production while assessing ecosystem co-benefits and soil pollutant risks; Soil Carbon Dynamics , specializing in black carbon's role in urban soil carbon sequestration; and Urban Forest Ecology , investigating how pollution and infrastructure encasement impact tree health and ecosystem services like heat mitigation. Her work consistently integrates field studies with policy-relevant applications for city planning. Analysis of her 2020-2025 publications reveals intensifying focus on climate adaptation, with dominant themes including urban food security quantification, soil contaminant bioavailability, green infrastructure performance, and urban tree resilience. Methodologically, she pioneers citizen science integration and interdisciplinary field measurements, yielding actionable insights for urban sustainability policy. Her major recognitions include: NERC Knowledge Exchange Fellow (2022-present) EPSRC Living with Environmental Change Fellow (2016-2021) Professor Edmondson supervises undergraduate literature reviews and research projects across multiple programs (MBiolSci, MEnvSci, MSc, MRes), mentoring the next generation of sustainability scientists. Her grant portfolio features competitive fellowships supporting urban ecosystem research with direct policy applications through partnerships with local governments and environmental NGOs. She directs the MYHarvest citizen science initiative and collaborates extensively with the University of Sheffield's Institute for Sustainable Food, leading a multidisciplinary team spanning soil science, ecology, and engineering to develop evidence-based strategies for resilient urban ecosystems.
Trond Vidar Hansen is a Professor at the Department of Pharmacy, University of Oslo , and leads the LIPCHEM research group . He collaborates with institutions including the University of Bergen and Vestlandets Innovasjonsselskap through the VITADEL project, which recently received NOK 5,000,000 in verification support from the Research Council of Norway. His research focuses on the synthesis and biological evaluation of specialized pro-resolving lipid mediators derived from omega-3 fatty acids, with applications in inflammation resolution, neuroinflammation, and drug development. University : University of Oslo Department : Department of Pharmacy Research Group : LIPCHEM Collaborations : University of Bergen, Vestlandets Innovasjonsselskap Research Interests : H Hansen's work centers on the organic synthesis of bioactive lipid derivatives, particularly pro-resolving mediators from omega-3 polyunsaturated fatty acids. His team investigates their roles in inflammatory disease models , neuroinflammation , and PPAR receptor activation , aiming to develop therapeutic agents for conditions like chronic pain, diabetes, and neurodegenerative disorders. The research integrates stereoselective chemistry , biochemical profiling , and pharmacological evaluation to validate these mediators' clinical potential. Recent Awards : 2025: NOK 2,000,000 verification support from Research Council of Norway 2025: Co-leader of NOK 5,000,000 VITADEL project Publications : His articles (2015–2024) reveal a focus on stereoselective synthesis of resolvins, protectins, and maresins, with applications in anti-inflammatory and neuroprotective therapies . Key subfields include omega-3 metabolite profiling , PPAR agonist design , and biosynthetic pathway elucidation , often utilizing human cell models and mouse disease models . Collaborative projects emphasize commercialization of academic research and translational medicine .
Ken Oakes is an Associate Professor in the Biology Department at Cape Breton University (CBU) and holds the Industrial Research Chair in Environmental Remediation. He specializes in environmental toxicology, nanotechnology, and aquatic ecosystems. With a Ph.D. from the University of Guelph and postdoctoral training at the University of Waterloo, his research focuses on reactive oxygen species, water treatment, and pollution mitigation. He has over 60 peer-reviewed publications and supervised numerous graduate/undergraduate theses. Key research areas include photocatalytic water treatment using TiO₂ composites, surface-enhanced Raman spectroscopy (SERS) for contaminant detection, and transdermal drug delivery via polymeric microneedles. His work addresses industrial effluent impacts on marine ecosystems and sustainable antifouling technologies. Recent studies investigate nanomaterials for environmental remediation and biomedical applications. Dr. Oakes has contributed to projects assessing pulp mill effluent effects on coastal ecosystems, copper-based Fenton chemistry for biofilm removal, and uranium extraction from water. His lab develops innovative solutions for environmental challenges, combining engineering, chemistry, and biology disciplines. Funding sources include industrial partnerships and academic grants focused on clean technologies.
Martin Fromm is a Professor of Clinical Pharmacology and Toxicology at Friedrich-Alexander University Erlangen-Nürnberg, where he has served as Director of the Institute of Experimental and Clinical Pharmacology and Toxicology since 2004. His career includes prior roles as Acting Professor (2002–2004), Group Leader (1999–2002), and postdoctoral fellowships at the Dr. Margarete-Fischer-Bosch Institute (1992–1996) and Vanderbilt University (1997–1999). Research Focus: Mechanisms of variable drug effects, drug transporters, medication safety, and biomarker development for transporter-mediated drug interactions. Publications: Over 170 original articles and 49 reviews with an h-index of 76 (24,000+ citations). Leadership: Chair of the University Hospital Erlangen's drug utilization committee and steering board of the Center of Clinical Studies. Scientific Awards: Top 3% Highly Cited Researcher (AD Scientific Index 2022–2024) Top 2% Highly Cited Researcher (Stanford List 2023) MSD Health Award (2021) Paul-Martini-Award (2001) Presidential Trainee Award (1998) Research Trends: His recent work integrates metabolomics, machine learning (LC-MS methods), and clinical studies to enhance medication safety in oncology and geriatrics. Earlier studies focus on transporter proteins (e.g., OCT2, MATE1, P-glycoprotein) and their role in drug absorption, metabolism, and interactions. Grants & Collaborations: Funded by DFG, BMBF, BMG, and Deutsche Krebshilfe. Active in ethics committees and clinical pharmacology societies.
Stephen A. Boyd is a University Distinguished Professor in the Department of Plant, Soil and Microbial Sciences within Michigan State University's College of Agriculture and Natural Resources. His research spans environmental chemistry and microbiology with a focus on soil systems. His educational background includes a B.S. in Chemistry from Central Michigan University (1975), and M.S. and Ph.D. in Soil Chemistry from Purdue University (1978, 1980). Dr. Boyd's research investigates organic contaminant movement in soil, microbial/catalytic degradation mechanisms, and remediation technologies for contaminated soils/sediments. His work features innovative approaches including chemically modified clays for contaminant sorption and degradation, mechanistic studies of toxicant interactions with natural/modified clays, and development of in-situ soil modification technologies. He extensively examines biodegradation of xenobiotics (particularly PCB reductive dechlorination) and bioavailability of soil-bound contaminants to degrading bacteria. His 15 most recent publications reveal strong trends in clay-based contaminant immobilization, pharmaceutical/water pollutant interactions, dioxin chemistry, and nanomaterial applications for environmental remediation, with dominant fields being environmental chemistry, soil science, and contaminant toxicology. University Distinguished Professor (MSU, 2005) Jackson Award in Soil Science (SSSA, 2004) Highly Cited Researcher (Institute for Scientific Information, 2002) Distinguished Faculty Award (MSU, 2001) Soil Science Research Award (SSSA, 1999) Dr. Boyd has secured significant research funding including a recent $750K USDA grant (2022) for PFAS mitigation research. His laboratory focuses on clay chemistry applications for environmental remediation, with notable breakthroughs in soil cleansing technologies and biochar applications. Current work emphasizes advanced contaminant degradation pathways and practical field applications of his soil modification technologies.
Anne Berit C. Samuelsen serves as Associate Professor at the Department of Pharmacy, University of Oslo, where she also holds the position of Head of Education. Her academic foundation includes a Cand.pharm. degree and Dr.scient. doctorate, establishing her expertise in pharmaceutical sciences. Her research centers on polysaccharides from natural sources—particularly higher plants, cereals, and fungi (Basidiomycota)—with specialized focus on β-glucans. Key interests include carbohydrate chemistry, pharmacognosy, and the development of biopolymer-based pharmaceutical applications. Her work bridges fundamental structural characterization with practical drug delivery solutions, notably through liposome coating technologies and immunomodulatory compound development. Recent publications reveal a strong trajectory in fungal polysaccharide research, particularly with Pleurotus eryngii and Albatrellus ovinus species. Her team employs advanced techniques like diffusion-ordered NMR spectroscopy to analyze polysaccharide structures while investigating biological activities related to immune receptor binding (Dectin-1, Toll-like receptors) and therapeutic applications. This work demonstrates consistent output in high-impact journals including Carbohydrate Polymers and ACS Applied Bio Materials . She actively contributes to academic instruction through courses such as FARM1150 (Pharmaceutically Oriented Biochemistry), FARM3100 (Pharmacognosy), and FARM5200 (Use of Biopolymers in Pharmaceuticals). Her leadership extends to the Bioactive Natural Substances and Health Effects (BioNatH) research group and the Glyconor Consortium, where she investigates natural product applications for health improvement.
Dr. Roselina Angel is a Professor in the Department of Animal and Avian Sciences at the University of Maryland's College of Agriculture and Natural Resources. With expertise in poultry nutrition, she holds a PhD in Poultry Nutrition from Iowa State University and has been with the university since 1998, initially joining as an Assistant Professor. Research Focus Areas Calcium and phosphorus metabolism in poultry Phytase and enzyme supplementation Environmental impact reduction Nutritional strategies for exotic animals Feed additive efficacy Mineral utilization optimization Her recent publications (2025–2023) concentrate on mechanistic modeling of mineral digestibility, circadian nutrient regulation in laying hens, and the environmental implications of poultry nutrition. These studies frequently examine interactions between dietary calcium/phosphorus ratios, phytase application, and ingredient selection across broilers and laying hens.
Prof. Flavio Anselmetti is a Full Professor of Quaternary Geology and Paleoclimatology at the University of Bern , where he has been employed since 2012. He also serves as the Managing Director of the Institute of Geological Sciences . Prior to this, he held significant roles at ETH Zurich, including SNSF Assistant Professor, and at EAWAG Dübendorf as Head of the Sedimentology Group, while remaining a Titular Professor at ETH Zurich until 2012. His academic training includes a Diploma in Geology (1990) from the University of Basel , followed by a PhD (1994) from ETH Zurich and University of Miami (USA) . He spent three years as a Postdoctoral Fellow and Research Associate at the University of Miami between 1994 and 1997. Paleoseismology : Using lacustrine and marine sediments to reconstruct earthquake and tsunami records Climate Change Studies : Investigating Holocene and Pleistocene climate shifts through sediment cores Sediment Dynamics : Analyzing source-to-sink systems and glacial sediment properties His recent publications focus on sedimentary archives in Science Advances , Quaternary Research , and Environmental Modelling and Software , with an emphasis on deep learning applications in sediment analysis , multi-proxy paleoenvironmental reconstructions , and human impact assessments over millennia. He has contributed to major projects in the Alpine foreland and Caribbean regions . Prof. Anselmetti leads the Quaternary Geology and Paleoclimatology Research Group and collaborates with international teams on ICDP-DOVE drilling campaigns and multibeam bathymetry mapping in Swiss lakes. His work extends to geohazard assessment , carbonate-siliciclastic shelf dynamics , and subaqueous fault analysis in active tectonic zones.
Professor Patrick Steel is a faculty member at Durham University in the Department of Chemistry . His work spans Synthetic Organic Chemistry , Organosilicon Chemistry , and Chemical Biology , with applications in pharmaceuticals, agrochemicals, and parasitic disease treatment. Research Highlights: Developing C-H borylation methods for pharmaceutical intermediates Exploring silene cycloadditions for alkene functionalization Designing small molecule probes for plant and parasite biology Collaborating with Todd Marder (Würzburg) and others in synthetic biology Key Collaborations: Partnerships with pharmaceutical companies (GSK, Pfizer) and academic teams focus on novel antileishmanial compounds and herbicide resistance mechanisms . His group's organosilicon work intersects with collaborations on stereoselective synthesis and natural product analogs . Recent Publications (2025-2021) demonstrate expertise in transition metal catalysis , chemical probe development , and neglected disease research . The 2023 Leishmania proteomics and 2022 miltefosine studies show translational impact.
Privatdozent Dr. Andreas Faust is a leading researcher at the European Institute for Molecular Imaging (EIMI) at the University of Münster, where he heads the Chemical Targeting Lab. His work focuses on developing innovative imaging agents for medical diagnostics, particularly in radiopharmaceutical chemistry and molecular imaging. He maintains strong affiliations with the Department of Nuclear Medicine at the University Hospital Münster and participates in the "Cells in Motion" excellence cluster, contributing to cutting-edge research at the intersection of chemistry, medicine, and imaging technology. Dr. Faust completed his chemistry studies at the University of Münster, earning his Diploma in 1999, followed by his doctoral degree (Dr. rer. nat.) in 2003 with research on artificial caffeine receptors. His academic journey continued with positions at the Department of Organic Chemistry and the Department of Nuclear Medicine before becoming head of the chemistry group at EIMI in 2011. Dr. Faust's research centers on organic and medicinal chemistry with specialization in radiopharmaceutical chemistry . His team develops novel tracers for diagnostic molecular imaging using positron emission tomography (PET), single-photon emission computed tomography (SPECT), optical imaging, and photoacoustic imaging. A significant portion of his work focuses on creating specific ligands for the alarmins S100A8/S100A9 and bacteria-specific tracers based on complex carbohydrates or siderophores. His research has important applications in inflammation imaging, infection diagnostics, and cancer theranostics, with emphasis on improving metabolic stability and target specificity of imaging agents. His publication record demonstrates consistent contributions to molecular imaging, with recent work emphasizing bacteria-specific PET tracers, inflammation imaging targeting S100 proteins, and novel optical imaging probes. The research shows a clear trajectory toward developing clinically applicable imaging agents with improved specificity and metabolic stability, particularly in the areas of infection diagnostics and inflammation monitoring. 2017: Best Poster Award at Symposium "Molecular Imaging Agents in Medicine," Groningen 2009: Young Investigator Award at Deutscher Röntgenkongress, Berlin 2005: Best Scientific Poster Award at 4th Annual Meeting of the Society of Molecular Imaging, Köln Dr. Faust leads multiple significant research projects, including as Coordinator of a project on immune cell distribution imaging (2019-2024) and as Principal Investigator for CRC-project A03 "Targeting of S100A8/A9 for imaging of inflammatory disorders" and research on vascular graft infections (both 2021-2024). His Chemical Targeting Lab comprises a multidisciplinary team working at the intersection of chemistry, microbiology, and medical imaging, securing substantial funding from the Innovative Medicines Initiative and DFG Collaborative Research Centre. The Chemical Targeting Lab maintains state-of-the-art facilities for chemical synthesis, radiochemistry, and biological testing. The lab collaborates extensively with microbiologists, clinicians, and imaging specialists to translate basic research into clinical applications. Current research directions include optimizing bacterial imaging probes for clinical diagnostics and developing new inflammation-specific tracers for early disease detection, with particular focus on S100A9-targeted imaging and siderophore-based bacterial detection systems.
Timothy B. Curry, M.D., Ph.D., is a Professor of Anesthesiology and Assistant Professor of Physiology at Mayo Clinic, Rochester, Minnesota. He holds academic roles including Vice Chair for Clinical Practice in the Department of Anesthesiology and Perioperative Medicine, and leads initiatives in individualized medicine through the Center for Individualized Medicine. His research focuses on autonomic nervous system regulation of cardiovascular and metabolic functions, employing advanced techniques such as microneurography and glucose clamping. Key interests include perioperative outcomes, environmental physiology, and hyperbaric medicine. Education: B.A. in Molecular Biology & Biochemistry (Middlebury College) M.D./Ph.D. via Medical Scientist Training Program (SUNY Buffalo) Residency in Anesthesiology (Mayo Clinic) Research Interests: Dr. Curry’s work spans autonomic nervous system physiology, metabolic syndrome mechanisms, and perioperative glycemic control. He leads the Human Integrative Physiology and Clinical Pharmacology Laboratory and collaborates globally on microneurography studies. Recent projects include investigating cerebral oxygen metabolism under hypoxia and developing genomic medicine training programs (COGENT). Awards: Emerald Award for Excellence (2015) Mayo Excellence in Leadership Award (2009) Multiple research and teaching accolades Grants & Leadership: Co-director of Mayo’s Clinomics Program, Team Leader for Perioperative Glucose Management, and Chair of multiple committees overseeing clinical practice and research. Labs & Teams: Directs the Human Integrative Physiology Lab and collaborates with the Clinical Research Unit. Active in multidisciplinary teams addressing autonomic dysfunction and precision medicine.
Joonhyuk Suh is an Assistant Professor in the Department of Food Science & Technology at the University of Georgia's College of Agricultural & Environmental Sciences. His research focuses on applying analytical chemistry and metabolomics/flavoromics to enhance food flavor, quality, and safety. Research Interests : Multidisciplinary food chemistry analysis Metabolite and flavor profiling Nut and fruit quality evaluation Dairy product flavor chemistry Food safety biomarkers Recent Publication Trends (2025-2022) show expertise in: Metabolomic evaluation of agricultural products Flavor chemistry in tropical fruits and nuts Food processing safety and contaminant analysis Plant-based food characterization Microbiome and nutritional interventions
Dr. Dirk de Beer is the leader of the Microsensor Group at the Max Planck Institute for Marine Microbiology in Bremen, Germany. His research focuses on the structure and function of marine sediments, investigating how microbial conversions (e.g., photosynthesis, chemoautotrophy, anaerobic nitrogen/carbon/sulfur cycling) are controlled by transport processes and how microbial species distributions are regulated in hot spots like seeps, microbial mats, and biofilms. His group employs advanced techniques such as microsensors and planar optodes to study high-resolution geochemical dynamics in marine systems. Key research areas include: Biogeochemical cycling of oxygen, sulfur, and carbon Microbial community interactions in sediments and mats Environmental regulation of microbial processes Reactive oxygen species in marine environments Coral bleaching and ocean acidification Recent publications highlight collaborations on arsenic cycling, hydrogen peroxide dynamics, and microbial respiration in extreme environments. Dr. de Beer's work is central to understanding how microbial processes influence global elemental cycles and climate regulation.
